Ling Su
Chief Development Officer at Skyline Therapeutics
Shanghai, China
Ling Su, Chief Development Officer at Skyline Therapeutics is an active investor based in Shanghai, China. This profile covers what Ling Su backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VC
- Stages
- SeedSeries ASeries B
- Invests in
- Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesRobotics & AutomationIoT & Connected DevicesManufacturing & Industrial
- Location
- Shanghai, China
- Typical check
- $1M
- Past investments
- 67
Notable investments
How to reach Ling Su
Angels and operators like Ling Su reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Frequently Asked Questions
What does Ling Su invest in?
Ling Su invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed, Series A and Series B. Match your sector and stage, then reach out with a personalized pitch.
How do I contact Ling Su?
Unlock Ling Su's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
Similar investors
Browse all investorsIs this you? Email team@roundfunded.com to update or remove your profile.
